NCT01500798View on ClinicalTrials.gov

A Pharmacodynamic Study of Measured Glomerular Filtration Rate in Patients With Chronic Kidney Disease and Type 2 Diabetes

PHASE1TerminatedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

November 1, 2012

Study Completion Date

October 1, 2013

Conditions
Chronic Kidney DiseaseType 2 Diabetes
Interventions
DRUG

20 mg bardoxolone methyl

20 mg, oral, once daily

DRUG

Placebo

Oral, once daily

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY